Search Results

Showing results 1011 - 1020 for leonard

The Walking Cure | Newsroom | Weill Cornell Medicine

...Leonard notes that the implications of Dr....

https://news.weill.cornell.edu/news/2015/09/the-walking-cure-janey-peterson

Convocation Recognizes Medical and PA Students | Newsroom | Weill Cornell Medicine

...Rideaux Shakirah Namuyomba Ssebyala The Paul Sherlock Prize in Internal Medicine Nathan Eric Matzko The Leonard...

https://news.weill.cornell.edu/news/2025/05/convocation-recognizes-medical-and-pa-students

B.H. Kean-Boxer Family Foundation Lecture in Global Health | Weill Department of Medicine

...Christopher Barley (Leonard Boxer was his patient) and Dr....

https://medicine.weill.cornell.edu/news/bh-kean-boxer-family-foundation-lecture-global-health

Patient preferences with MCL treatment | Sandra and Edward Meyer Cancer Center

...Leonard reflects on progress for lymphoma patients Researcher's resolve leads to breakthrough drug The...

https://meyercancer.weill.cornell.edu/news/2017-05-05/patient-preferences-mcl-treatment

Potential of immunotherapy in MCL landscape | Sandra and Edward Meyer Cancer Center

...Leonard reflects on progress for lymphoma patients Researcher's resolve leads to breakthrough drug The...

https://meyercancer.weill.cornell.edu/news/2017-08-18/potential-immunotherapy-mcl-landscape

September 2021 EIPM Director's Memo | Englander Institute for Precision Medicine

...Leonard, Richard Furman, and Peter Martin was published in the American Journal of Hematology on August...

https://eipm.weill.cornell.edu/news/september-2021-eipm-directors-memo

Class of 2015 | Department of Anesthesiology

...Medical School: University of New South Wales Eric Chavoustie Medical School: University of Miami Leonard...

https://anesthesiology.weill.cornell.edu/education/residency-program/residency-classes/class-of-2015

A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma | Joint Clinical Trials Office

...Manhattan Contact(s) Katie Greig 212-746-6738 kag9156@med.cornell.edu Primary Investigator(s) John P Leonard...

https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-1b3-double-blind-randomized-active-controlled-3-stage-biomarker-adaptive-study-of-tazemetostat-or-placebo-in-combination-with-lenalidomide-plus-rituximab-in-subjects-with-relapsedrefractory-follicular-lymphoma

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas. | Cerchietti Research Lab

...Phillip JM, Marullo R, Tikhonova E, Kotlov N, Patel J, Yang SNing, Yang L, Taldone T, Thieblemont C, Leonard...

https://cerchiettilab.weill.cornell.edu/publications/oncogenic-hsp90-facilitates-metabolic-alterations-aggressive-b-cell-lymphomas

Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. | Hartman Institute for Therapeutic Organ Regeneration

...Publication 2006 Authors Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M, Hempstead B, Leonard...

https://hartmaninstitute.weill.cornell.edu/magnitude-stromal-hemangiogenesis-correlates-histologic-subtype-non-hodgkins-lymphoma

Showing results 1011 - 1020 for leonard